The inaugural Microbiome World Congress Americas 2017 will bring together leading pharma, biotechs, academic researchers, and their partners to Washington DC in order to discuss how to successfully commercialize microbiome-based diagnostics, therapeutics, adjunct therapies and direct-to-consumer services and products.
With leading researchers like Jack Gilbert of The University of Chicago, and Elaine Hsiao of UCLA, alongside the FDA and leading pharma and biotechs such as Janssen, Pfizer, Seres Therapeutics and Enterome, this will be a forum for the entire community to come together to learn, network and create the partnerships necessary to develop microbiome-based diagnostics and therapies. At the same time, academic researchers will gain key insights into how to develop and commercialize their research.
The 2017 edition will feature:
50+ speakers from pharma, biotechs & academic researchers
2 days of unrivalled networking
A brand new Pitch & Partner breakout session where biotech start-ups will showcase their innovations
Co-location with the World Precision Medicine Congress USA 2017